Target intelligence / Profile preview

Tyrosine-protein kinase Met (MET)

Target
MET
Molecular classification
Receptor, Tyrosine Kinase, Enzyme
01

Overview

MET, also known as the hepatocyte growth factor receptor (HGFR), is a proto-oncogenic receptor tyrosine kinase that plays a critical role in regulating cellular processes such as proliferation, survival, morphogenesis, and motility. The endogenous ligand for MET is hepatocyte growth factor (HGF). Mutations or amplification of MET are associated with various cancers including papillary renal cell carcinoma. Both germline mutations/SNPs and somatic mutations have been reported to drive oncogenic transformation via aberrant MET signaling.

Other names
Hepatocyte Growth Factor Receptor (HGFR)c-MET
02

Mechanism of action

Tyrosine kinase inhibition

03

Biological functions

Cell proliferationCell survivalMorphogenesisCell motilitySignal transductionTissue repairTissue regeneration
04

Disease associations

Cancer
05

Safety considerations

Aberrant MET signaling can drive oncogenic transformation

Beyond the preview

Go deeper on Tyrosine-protein kinase Met (MET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosine-protein kinase Met (MET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call